亞太地區基於電動車的液體活體組織切片市場：分析與預測（2023-2032）

亞太地區基於電動車的液體活體組織切片市場規模預計將從 2023 年的 1,282 萬美元增至 2032 年的 7,475 萬美元，預測期內複合年成長率為 21.64%。

預計該市場將在技術不斷進步、醫療保健提供者的接受度不斷提高以及對個人化醫療方法的日益重視的推動下成長。

亞太地區基於電動車的液體活體組織切片市場正在經歷顯著成長。這一成長主要歸功於醫療技術的持續進步以及全部區域醫療保健提供者擴大採用液體活體組織切片技術。液體活體組織切片正在成為一種用於早期檢測癌症和監測治療效果的非侵入性方法，這與該地區醫療保健環境中對個人化醫療日益成長的興趣相吻合。由於研發活動激增以及將先進技術引入醫療保健系統，中國、日本和韓國等國家處於這一趨勢的前沿。此外，該地區龐大且多樣化的人口為液體活體組織切片應用提供了豐富的患者群。因此，該地區的市場將顯著成長，並為公司和相關利益者提供利潤豐厚的機會。

本報告調查了亞太地區基於電動車的液體活體組織切片市場，並提供了市場概況、市場成長的各種影響因素分析、市場規模趨勢和預測、主要國家的詳細分析以及主要企業的分析。我正在總結。

市場分類

細分 1：按國家/地區

• 中國
• 日本
• 韓國
• 澳洲
• 印度
• 新加坡
• 其他

目錄

執行摘要

第1章 研究範圍

第2章調查方法

第3章市場概況

• 市場概況
• 基於EV的液體活體組織切片的現狀和未來
• 目前的市場規模和成長潛力
• COVID-19 對基於 EV 的液體活體組織切片市場的影響

第4章 EV隔離與分析方法

• 概述
• 分離方法
  • 使用超速離心的 EV 分離技術
  • 使用基於尺寸的方法的EV分離技術
  • 採用親和性和法的EV分離技術
  • 採用沉澱法的EV分離技術
  • 利用微流控技術的EV分離技術
  • 使用市售套件的 EV 隔離技術
  • EV隔離方法的優點和缺點
  • 胞外體分離的新方法
• 分析方法
  • EV分析方法的優缺點

第5章 EV液體活體組織切片市場（按地區）

• 概述
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 新加坡
  • 其他

第6章 公司簡介

• 公司簡介

“The Asia-Pacific EV-Based Liquid Biopsy Market Expected to Reach $74.75 Million by 2032.”

Introduction to Asia-Pacific EV-Based Liquid Biopsy Market

The Asia-Pacific EV-based liquid biopsy market is expected to reach $74.75 million by 2032 from $12.82 million in 2023, at a CAGR of 21.64% during the forecast period. The market for EV-based liquid biopsy is anticipated to see growth propelled by continuous technological progress, rising acceptance by healthcare providers, and an increasing emphasis on personalized medical approaches.

Market Introduction

The Asia-Pacific (APAC) region is witnessing significant growth in the EV-based liquid biopsy market. This expansion is primarily attributed to ongoing advancements in healthcare technology and the increasing adoption of liquid biopsy techniques by healthcare providers across the region. Liquid biopsies are gaining prominence as a non-invasive method for early cancer detection and monitoring treatment response, aligning with the growing focus on personalized medicine in the APAC healthcare landscape. Countries like China, Japan, and South Korea are at the forefront of this trend, with a surge in research and development activities and the incorporation of advanced technologies into healthcare systems. Additionally, the region's large and diverse population offers a substantial patient pool for liquid biopsy applications. As a result, the APAC EV-based liquid biopsy market is poised for significant growth, presenting lucrative opportunities for healthcare companies and stakeholders in the region's dynamic healthcare sector.

Market Segmentation:

Segmentation 1: by Country

• China
• Japan
• South Korea
• Australia
• India
• Singapore
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: EV-based liquid biopsy has tremendous growth potential due to its ability to revolutionize non-invasive cancer detection and monitoring. By analyzing the cargo of EVs, researchers can gain insights into the presence, type, and characteristics of tumors without directly accessing the tumor site.

Competitive Strategy: Key players in the APAC EV-based liquid biopsy market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC EV-based liquid biopsy market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Research Scope

• 1.1. Key Questions Answered in the Report:

2. Research Methodology

• 2.1. EV-Based Liquid Biopsy Market: Research Methodology
• 2.2. Primary Data Sources
• 2.3. Secondary Data Sources
• 2.4. Market Estimation Model
• 2.5. Criteria for Company Profiling

3. Markets Overview

• 3.1. Market Introduction
• 3.2. Current and Future State of EV-Based Liquid Biopsy in Industries
• 3.3. Current Market Size and Growth Potential, $Million, 2022-2032
• 3.4. COVID-19 Impact on EV-based Liquid Biopsy Market
  • 3.4.1. Impact on Operations
  • 3.4.2. COVID-19 Impact: Current Scenario of the Market

4. Methods of EV Isolation and Analysis

• 4.1. Overview
  • 4.1.1. Evs Introduction
• 4.2. Isolation Methods
  • 4.2.1. EV Isolation Techniques Utilizing Ultracentrifugation Methods
    • 4.2.1.1. Differential Ultracentrifugation
    • 4.2.1.2. Density Gradient Centrifugation
    • 4.2.1.3. Moving Zone or Rate-Zonal Centrifugation
    • 4.2.1.4. Isopycnic Centrifugation
  • 4.2.2. EV Isolation Techniques Utilizing Size-Based Methods
    • 4.2.2.1. Ultrafiltration
    • 4.2.2.2. Sequential Filtration
    • 4.2.2.3. Size Exclusion Chromatography (SEC)
    • 4.2.2.4. Flow Field-Flow Fractionation (FFFF)
    • 4.2.2.5. Hydrostatic Filtration Dialysis (HFD)
  • 4.2.3. EV Isolation Techniques Utilizing Immunoaffinity Methods
    • 4.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 4.2.3.2. Magneto-Immunoprecipitation
  • 4.2.4. EV Isolation Techniques Utilizing Precipitation Methods
    • 4.2.4.1. Polyethylene Glycol (PEG) Precipitation
    • 4.2.4.2. Lectin Induced Agglutination
  • 4.2.5. EV Isolation Techniques Utilizing Microfluidic Technology
  • 4.2.6. EV Isolation Techniques Utilizing Commercial Kits
  • 4.2.7. Advantages and Disadvantages of the EV Isolation Methods
  • 4.2.8. Novel Approaches for Exosome Isolation
• 4.3. Analysis Methods
  • 4.3.1. Advantages and Disadvantages of Analysis Methods for Evs

5. EV-Based Liquid Biopsy Market (by Region), $Million, 2022-2032

• 5.1. Overview
• 5.2. Asia-Pacific
  • 5.2.1. China
  • 5.2.2. Japan
  • 5.2.3. India
  • 5.2.4. South Korea
  • 5.2.5. Australia
  • 5.2.6. Singapore
  • 5.2.7. Rest-of-Asia-Pacific

6. Company Profiles

• 6.1. Company Overview
  • 6.1.1. Horiba Ltd.
    • 6.1.1.1. Company Overview
    • 6.1.1.2. Role of Horiba Ltd. in the EV-Based Liquid Biopsy Market
    • 6.1.1.3. Major Products: Key Specifications
    • 6.1.1.4. Key Competitors
    • 6.1.1.5. Analyst Perspective
  • 6.1.2. Takara Bio Inc.
    • 6.1.2.1. Company Overview
    • 6.1.2.2. Role of Takara Bio Inc. in the EV-Based Liquid Biopsy Market
    • 6.1.2.3. Major Products: Key Specifications
    • 6.1.2.4. Key Competitors
    • 6.1.2.5. Analyst Perspective

List of Figures

• Figure 1: EV-Based Liquid Biopsy Market (by Region), 2022
• Figure 2: EV-Based Liquid Biopsy Market Methodology
• Figure 3: Primary Research Methodology
• Figure 4: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 5: Top-Down Approach (Segment-Wise Analysis)
• Figure 6: Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 7: Subtypes of Evs
• Figure 8: Methods of EV-Isolation from Biofluids
• Figure 9: Workflow of Differential Ultracentrifugation for Exosome Isolation
• Figure 10: Methods of EV-Analysis
• Figure 11: EV-Based Liquid Biopsy Market Snapshot (by Region)
• Figure 12: EV-Based Liquid Biopsy Market (by Region), $Million, 2022-2032
• Figure 13: Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 14: Asia-Pacific: Market Dynamics
• Figure 15: Asia-Pacific EV-Based Liquid Biopsy Market (by Country), $Million, 2022-2032
• Figure 16: China EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 17: Japan EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 18: India EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 19: South Korea EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 20: Australia EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 21: Singapore EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 22: Rest-of-Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 23: Total Number of Companies Profiled
• Figure 24: Horiba Ltd.: Product Portfolio
• Figure 25: Takara Bio Inc.: Product Portfolio

List of Tables

• Table 1: Current and Future State of EV-Based Liquid Biopsy in Industries
• Table 2: Example of Few Commercial Kits Available for EV Isolation
• Table 3: Advantages and Disadvantages of the EV Isolation Methods
• Table 4: Emerging Methods for the Isolation of Exosomes
• Table 5: Advantages and Disadvantages of Analysis Methods for Evs